Marqibo is an anti-cancer drug that works by interfering with the growth of cancer cells in the human body hence slowing down the spread of these cells in the body. Marqibo is used in the treatment of a type of blood cancer referred to as Philadelphia chromosome negative acute lymphoblastic leukemia (ALL). Marqibo is normally given after other cancer drugs have been administered with no success.
Drug Name: Marqibo
Generic name: Vincristine sulfate